SPIE acquires Swiss life‑sciences engineering firm nimeg ag
- SPIE has acquired nimeg ag to expand industrial services in Switzerland and the life sciences market.
- nimeg is based in Baden‑Dättwil (Aargau) and specialises in engineering, planning and project management in GMP environments for EPCMV projects.
- nimeg reported approximately €5 million in turnover in 2025.
- SPIE says the combined group will offer EPC projects as a general contractor and integrated end‑to‑end solutions on the Swiss market.
Deal overview
SPIE has acquired nimeg ag to strengthen its position on the pharmaceutical and biotechnological installations market and to develop its industrial services offering in Switzerland.
Company profile
nimeg ag is headquartered in Baden‑Dättwil (canton of Aargau) and provides engineering, planning and project management services in GMP environments for EPCMV (Engineering, Procurement, Construction Management and Validation) projects. The company serves clients across pharmacy, chemistry, biotechnology and medical devices and posted about €5 million in turnover in 2025.
Strategic impact
SPIE intends to combine nimeg's engineering skills with its own capabilities to execute complete EPCMV/EPC projects as a general contractor on the Swiss market and to deliver integrated, end‑to‑end solutions to life‑science clients.
Management comments
nimeg's managing director said the acquisition will enable larger and more technically demanding projects and better opportunities for clients and employees. SPIE executives noted the move strengthens their industrial services expertise in the fast‑growing life sciences sector and welcomed the nimeg team.
Source: SPIE
